欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DE/H/7259/001
药品名称Sugammadex Atnahs 100 mg/ml solution for injection
活性成分
    • Sugammadex sodium 100.0 mg/ml
剂型Solution for injection
上市许可持有人Atnahs Pharma Netherlands B.V. Copenhagen Towers Ørestads Boulevard 108, 5.tv DK-2300 Kopenhagen S. Denmark
参考成员国 - 产品名称Germany (DE)
Sugammadex Atnahs 100 mg/ml Injektionslösung
互认成员国 - 产品名称
    • Italy (IT)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Belgium (BE)
      Sugammadex Atnahs 100 mg/ml oplossing voor injectie
    • Netherlands (NL)
    • Austria (AT)
许可日期2023/05/25
最近更新日期2024/03/25
药物ATC编码
    • V03AB35 sugammadex
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Multiple (Copy) Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase